Search Results
583 items found for "G-protein coupled receptors (GPCR)"
- Learn more about Neurocrine Biosciences with their new video
Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Dr. Alexander S. Hauser receives the Bachem award for peptide science
November 2021 Read more at the source #DrGPCR #GPCR #IndustryNews
- Dr. Thomas P. Sakmar receives an honorary doctorate from Karolinska Institute
Read more at the source #DrGPCR #GPCR #IndustryNews
- Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
Read more at the source #DrGPCR #GPCR #IndustryNews
- New role of β-arrestins in MOR signaling
(ORs): μ-opioid receptor (MOR), κ-opioid receptor (KOR), δ-opioid receptor (DOR) which are expressed Opioid receptors belong to class A of G protein-coupled receptors or GPCRs and signaled mainly through that have addressed the differences in the mechanisms of transduction triggered by MOR, reporting that G-protein This report highlights a mechanism of β-arrestin pathway activation dependent on G protein activation These findings highlight how G proteins and β-arrestins are involved in driving intracellular signaling
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...
accelerate and improve the prediction of first-in-class small molecule agonists for a challenging orphan GPCR #ai #biotech #systemsbiology #drugdiscovery #gpcr #deeptech #orphandrugs #pharma #partnerships #AI4drugdiscovery " Read more at the source #DrGPCR #GPCR #IndustryNews
- Exscientia welcomes Richard J. Law, as their new Chief Business Officer
Read more at the source #DrGPCR #GPCR #IndustryNews
- Exscientia is 10 years old this July!
#artificialintelligence #drugdesign #drugdiscovery" Read more at the source #DrGPCR #GPCR #IndustryNews
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
trust us in the generation of their monoclonal antibodies against small molecules and transmembrane receptors #technology #lifescience #immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies pharmaindustry #pharmaceuticals #oncology #healthcare #drugdevelopment" Read more at the source #DrGPCR #GPCR
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
yesterday for contributions to the field of mass spectrometry and establishing it as method to analyse proteins #DrugDiscovery #MassSpec #Award #massspectrometry" Read more at the source #DrGPCR #GPCR #IndustryNews
- AcroScreen co-founder Margaux Duchamp has been selected as a 30 under 30 Europe Forbes ranking 2022
#ForbesUnder30 #ArcoScreen #sciences #EPFL" Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia
Read more at the source #DrGPCR #GPCR #IndustryNews
- G.CLIPS biotech is 2 years old this month!
forward for more 🎊 #team #grateful #biotech #work #birthdaycelebration" Read more at the source #DrGPCR #GPCR
- AELIS PHARMA launches their IPO for €25 million
innovation #traitements #addiction #cannabis #Trisomie21 #Downsyndrome" Read more at the source #DrGPCR #GPCR
- Chronic itch: emerging treatments following new research concepts
Current progress in our knowledge of the itch processing, the numerous mediators and receptors involved Currently, inhibitors of IL-31, IL-4/13, NK1 receptors, opioids and cannabinoids, JAK, PDE4 or TRP are However, many new targets, such as Mas-related GPCRs and unexpected new pathways need to be also explored
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
GPCR ecosystem members! GPCR ecosystem. Top candidates will have a solid foundation in GPCR pharmacology as well as some experience in drug discovery GPCR
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
We show that locally restricted suppression of postsynaptic cAMP levels or of cAMP-dependent protein-kinase Given that postsynaptic latrophilin adhesion-GPCRs drive synapse formation and produce cAMP, we suggest
- 4GPCRnet - International Symposium
SEPTEMBER 26-29, 2022 (Leipzig, Germany) 4GPCRnet meeting bringing together four of the biggest GPCR Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded